FEATURES OF DOPPLER INDICATORS OF UTERINE BLOOD FLOW IN PATIENTS WITH ADENOMYOSIS

М. E. Azizova, Islam Magalov
In: World of Medicine and Biology · 2024 · vol. 20(87) , pp. 11 · doi:10.26724/2079-8334-2024-1-87-11-15 · W4393373414
article OA: hybrid CC0
🔓 Open OA copy Full text JSON View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06+body, 2026-06-09 ⓘ

This study examined 224 adenomyosis patients and 84 controls, finding the highest incidence in women aged 36-40 and common co-occurring conditions, with significant resistance index differences between adenomyosis and control groups.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-10 · read from full text ⓘ

This prospective clinical study evaluated uterine blood-flow Doppler parameters alongside clinical, laboratory, and instrumental findings in 224 women aged 30–50 with adenomyosis, comparing diffuse (106) versus nodular (118) forms against 84 reproductive-age controls without gynecologic disease and with regular ovulatory cycles. The authors reported that the greatest number of adenomyosis cases occurred in the 36–40 year age range, and that cervix diseases, uterine fibroids, and pelvic inflammatory diseases were common comorbidities across adenomyosis forms. Resistance index values differed significantly between adenomyosis groups in both the follicular and luteal phases (p<0.05). A major limitation explicitly reflected in the abstract is that the study’s detailed methodology and the Doppler endpoints beyond resistance index are not described in the provided text. This paper is centrally about endometriosis? (no) — it focuses on adenomyosis, specifically features of Doppler indicators of uterine blood flow for diagnosing and distinguishing diffuse versus nodular adenomyosis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 4,971 characters · extracted from oa-html · click to expand
Clinical medicine FEATURES OF DOPPLER INDICATORS OF UTERINE BLOOD FLOW IN PATIENTS WITH ADENOMYOSIS Published 2024-02-14 Authors: МA М.E. Azizova IM I.Sh. Magalov - Abstract: - The purpose of study was to establish the incidence, clinical and anamnestic features of patients with adenomyosis. A comprehensive clinical, laboratory and instrumental prospective examination was carried out on 224 patients aged 30 to 50 years (average age – 42.0±1.8 years) with adenomyosis. These patients constituted the main study group. Patients of the main group were divided into 2 subgroups depending on the form of adenomyosis (Group I – diffuse form – 106 women, Group II – nodular form – 118 women). The control group consisted of 84 relatively healthy women of reproductive age, with a regular ovulatory menstrual cycle and no history of gynecological diseases. The largest number of adenomyosis are registered in patients aged 36–40 years – 92 women, 41.1±3.3 %. The most common pathologies in patients with various forms of the adenomyosis were the diseases of the cervix (114 women, 50.89±3.3 %), uterine fibroids (113 women, 50.45±3.4 %) and inflammatory diseases of the pelvic organs (113 women, 50.45±3.4 %). Resistance index values in the follicular phase and luteal phase have statistically significant differences between groups of patients with adenomyosis (p<0.05). - Keywords: - adenomyosis diagnosis resistance index blood flow uterus differential diagnosis - References: - - Abrão MS, Andres MP, Barbosa RN, Bassi MA, Kho RM. Optimizing Perioperative Outcomes with Selective Bowel Resection Following an Algorithm Based on Preoperative Imaging for Bowel Endometriosis. J Minim Invasive Gynecol. 2020 May-Jun;27(4):883–891. doi: 10.1016/j.jmig.2019.06.010. - Artymuk N, Zotova O, Gulyaeva L. Adenomyosis: genetics of estrogen metabolism. Horm Mol Biol Clin Investig. 2019 Mar 15;37(2). doi: 10.1515/hmbci-2018-0069. - Dessouky R, Gamil SA, Nada MG, Mousa R, Libda Y. Management of uterine adenomyosis: current trends and uterine artery embolization as a potential alternative to hysterectomy. Insights Imaging. 2019 Apr 27;10(1):48. doi: 10.1186/s13244-019-0732-8. - Donnez O, Donnez J. Gonadotropin-releasing hormone antagonist (linzagolix): a new therapy for uterine adenomyosis. Fertil Steril. 2020 Sep;114(3):640–645. doi: 10.1016/j.fertnstert.2020.04.017. - Dueholm M. Minimally invasive treatment of adenomyosis. Best Pract Res Clin Obstet Gynaecol. 2018 Aug;51:119-137. doi: 10.1016/j.bpobgyn.2018.01.016. - Harada T, Khine YM, Kaponis A, Nikellis T, Decavalas G, Taniguchi F. The Impact of Adenomyosis on Women's Fertility. Obstet Gynecol Surv. 2016 Sep;71(9):557-68. doi: 10.1097/OGX.0000000000000346. - Hashimoto A, Iriyama T, Sayama S, Nakayama T, Komatsu A, Miyauchi A, et al. Adenomyosis and adverse perinatal outcomes: increased risk of second trimester miscarriage, preeclampsia, and placental malposition. J Matern Fetal Neonatal Med. 2018 Feb;31(3):364–369. doi: 10.1080/14767058.2017.1285895. - Khalifa MA, Atri M, Klein ME, Ghatak S, Murugan P. Adenomyosis As a Confounder to Accurate Endometrial Cancer Staging. Semin Ultrasound CT MR. 2019 Aug;40(4):358–363. doi: 10.1053/j.sult.2019.04.004. - Lazzeri L, Morosetti G, Centini G, Monti G, Zupi E, Piccione E, et al. A sonographic classification of adenomyosis: interobserver reproducibility in the evaluation of type and degree of the myometrial involvement. Fertil Steril. 2018 Nov;110(6):1154–1161.e3. doi: 10.1016/j.fertnstert.2018.06.031. - Orlova YuA, Hromova AM, Ketova OM, Liakhovska TYu, Martynenko VB, Krutikova EI. Aseptic inflammation as the essential link in the pathogenesis of endometrioid disease. Medicni perspektivi. 2023;28(3):55–61. https://doi.org/10.26641/2307-0404.2023.3.288961 - Osada H. Uterine adenomyosis and adenomyoma: the surgical approach. Fertil Steril. 2018 Mar;109(3):406-417. doi: 10.1016/j.fertnstert.2018.01.032. 12.Schrager S, Yogendran L, Marquez CM, Sadowski EA. Adenomyosis: Diagnosis and Management. Am Fam Physician. 2022 Jan 1;105(1):33–38. - Szubert M, Koziróg E, Olszak O, Krygier-Kurz K, Kazmierczak J, Wilczynski J. Adenomyosis and Infertility-Review of Medical and Surgical Approaches. Int J Environ Res Public Health. 2021 Jan 30;18(3):1235. doi: 10.3390/ijerph18031235. - Yu O, Schulze-Rath R, Grafton J, et al.; Adenomyosis incidence, prevalence and treatment: United States population-based study 2006 – 2015. Am J Obstet Gynecol. 2020;223(1):94.e1–94.e10. - Zhu J, Liu S, Gao D. Application of Color Doppler Ultrasound in Microscopic Imaging Diagnosis of Adenomyosis. Scanning. 2022 May 31;2022:2366871. doi: 10.1155/2022/2366871. - Publication: - «World of Medicine and Biology» Vol. 20 No. 87 (2024) , с. 11-15 УДК 618.14–006.514.01.01 How to Cite FEATURES OF DOPPLER INDICATORS OF UTERINE BLOOD FLOW IN PATIENTS WITH ADENOMYOSIS. (2024). World of Medicine and Biology, 20(87), 11-15. https://doi.org/10.26724/2079-8334-2024-1-87-11-15 Share

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-html ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

adenomyosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (14)

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0 · commercial use OK